v3.24.0.1
CONSOLIDATED STATEMENTS OF REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-redeemable Non-Controlling Interests
Beginning balance at Dec. 31, 2020     $ 787            
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Re-measurement of non-controlling interest $ (1,058)   1,052   $ (1,058)        
Acquisition of non-controlling interests     (1,194)            
Derecognition of non-controlling interests upon divestiture (701)   (356)           $ (701)
Foreign currency translation adjustment 57           $ 57    
Net income (loss)     (85)            
Ending balance at Dec. 31, 2021     204            
Beginning balance (in shares) at Dec. 31, 2020       1,849,794          
Beginning balance at Dec. 31, 2020 12,967 $ (243)   $ 0 35,931 $ (243) (535) $ (23,130) 701
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       9,440          
Exercise of stock options 101       101        
Stock-based compensation 1,204       1,204        
Reclassification of share-based award liability to additional paid-in capital 4       4        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       2,770          
Issuance of common stock under the Employee Stock Purchase Plan 107       107        
Issuance of common stock as consideration for acquisitions (in shares)       19,377          
Issuance of common stock as consideration for acquisitions 929       929        
Issuance of common stock for settlement of Careem Convertible Notes (in shares)       4,225          
Issuance of common stock for settlement of Careem Convertible Notes $ 232       232        
Issuance of common stock for settlement of contingent consideration liability (in shares) 2,252                
Issuance of common stock for settlement of contingent consideration liability $ 102       102        
Issuance of restricted stock awards, subject to repurchase, in connection with acquisition of non-controlling interest (in shares)       4,641          
Acquisition of non-controlling interests (in shares)       20,641          
Acquisition of non-controlling interests 1,327       1,327        
Recognition of non-controlling interest upon sale of Freight Holding preferred stock 675               675
Issuance of common stock for settlement of RSUs (in shares)       36,703          
Shares withheld related to net share settlement (in shares)       (527)          
Shares withheld related to net share settlement (28)       (28)        
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax (46)           (46)    
Foreign currency translation adjustment 57           57    
Net income (loss) (484)             (496) 12
Ending balance (in shares) at Dec. 31, 2021       1,949,316          
Ending balance at Dec. 31, 2021 15,145     $ 0 38,608   (524) (23,626) 687
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Foreign currency translation adjustment 81   (3)       81    
Recognition of non-controlling interest upon capital investment     18            
Issuance of Freight subsidiary preferred stock 5   250           5
Net income (loss)     (39)            
Ending balance at Dec. 31, 2022     430            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       4,151          
Exercise of stock options 19       19        
Stock-based compensation 1,843       1,843        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       4,599          
Issuance of common stock under the Employee Stock Purchase Plan 92       92        
Issuance of common stock for settlement of contingent consideration liability (in shares)       132          
Issuance of common stock for settlement of contingent consideration liability 5       5        
Issuance of common stock for settlement of RSUs (in shares)       47,828          
Shares withheld related to net share settlement (in shares)       (540)          
Shares withheld related to net share settlement (17)       (17)        
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 0                
Foreign currency translation adjustment 81   (3)       81    
Net income (loss) $ (9,099)             (9,141) 42
Ending balance (in shares) at Dec. 31, 2022 2,005,486     2,005,486          
Ending balance at Dec. 31, 2022 $ 8,074     $ 0 40,550   (443) (32,767) 734
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Re-measurement of non-controlling interest (286)       (286)        
Foreign currency translation adjustment 17           17    
Net income (loss)     (62)            
Ending balance at Dec. 31, 2023     $ 654            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       7,747          
Exercise of stock options 46       46        
Stock-based compensation 1,983       1,983        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       5,578          
Issuance of common stock under the Employee Stock Purchase Plan 130       130        
Issuance of common stock for settlement of RSUs (in shares)       53,027          
Shares withheld related to net share settlement (in shares)       (435)          
Shares withheld related to net share settlement (18)       (18)        
Repurchase of outstanding shares (in shares)       (259)          
Purchase of capped calls (141)                
Unrealized gain (loss) on investments in available-for-sale debt securities, net of tax 5           5    
Foreign currency translation adjustment 17           17    
Net income (loss) $ 2,218             2,173 45
Ending balance (in shares) at Dec. 31, 2023 2,071,144     2,071,144          
Ending balance at Dec. 31, 2023 $ 12,028     $ 0 $ 42,264   $ (421) $ (30,594) $ 779